N-(4-methoxy-3-(4-methylpiperazin-1-yl)phenyl)-3-methyl-4-(pyridin-4-yl)benzamide

Catalog No. :
ACYZTG524
CAS No. :
148547-33-5
Molecular Formula :
C25H28N4O2
Molecular Weight :
416.52

IUPAC Name:N-(4-methoxy-3-(4-methylpiperazin-1-yl)phenyl)-3-methyl-4-(pyridin-4-yl)benzamide

N-(4-methoxy-3-(4-methylpiperazin-1-yl)phenyl)-3-methyl-4-(pyridin-4-yl)benzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(4-methoxy-3-(4-methylpiperazin-1-yl)phenyl)-3-methyl-4-(pyridin-4-yl)benzamide
IUPAC NameN-(4-methoxy-3-(4-methylpiperazin-1-yl)phenyl)-3-methyl-4-(pyridin-4-yl)benzamide
MDL No.MFCD00918566
Molecular FormulaC25H28N4O2
Molecular Weight416.52
SMILESCOC1=CC=C(NC(=O)C2=CC=C(C3=CC=NC=C3)C(C)=C2)C=C1N1CCN(C)CC1
InChI KeyGNOXPYACARZYMW-UHFFFAOYSA-N
SynonymN-[4-Methoxy-3-(4-methylpiperazin-1-yl)phenyl]-3-methyl-4-(pyridin-4-yl)benzamide
CAS No.148547-33-5
PubChem CID5311130

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACYZTG524 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIDLP204 route compound structure diagram
    ACIDLP204913835-65-1 In Stock
  4. Then
  5. ACYZTG524 route product structure diagram
    ACYZTG524148547-33-5
Inquiry

2. ACYZTG524 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIDLP204 route compound structure diagram
    ACIDLP204913835-65-1 In Stock
  4. Then
  5. ACYZTG524 route product structure diagram
    ACYZTG524148547-33-5
Inquiry

Comments (0)